Similar articles

• [The significance of the PAS-reaction in myeloproliferative diseases].

  Krug K, Stenzel L. Krug K, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1969;91(2):307-13. Folia Haematol Int Mag Klin Morphol Blutforsch. 1969. PMID: 4184596 German. No abstract available.
• Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.

  Macavei I, Galatâr N. Macavei I, et al. Morphol Embryol (Bucur). 1989 Apr-Jun;35(2):117-27. Morphol Embryol (Bucur). 1989. PMID: 2529429
• [New possibilities in the differential diagnosis of polycythemia vera and myelofibrosis using radioiron].

  Montz R, Schneider C. Montz R, et al. Radiobiol Radiother (Berl). 1968;9(1):25-32. Radiobiol Radiother (Berl). 1968. PMID: 5679632 German. No abstract available.
• Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.

  Orazi A. Orazi A. Pathobiology. 2007;74(2):97-114. doi: 10.1159/000101709. Pathobiology. 2007. PMID: 17587881 Review.
• Definition, clinical features and diagnosis of polycythaemia vera.

  Gilbert HS. Gilbert HS. Clin Haematol. 1975 Jun;4(2):263-90. Clin Haematol. 1975. PMID: 1102188 Review. No abstract available.